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Despite  the  importance  of adhesive  cell  interactions  in  development  and 
differentiation, progress in elucidating the underlying molecular mechanisms has 
been slow. The  immune  system has been extensively studied as a  model,  both 
because its cells circulate and can be readily obtained in suspension, and because 
adhesive interactions between T  helper cells and macrophages (1, 2) and between 
T  cytolytic cells and target cells (3, 4) are extremely important  in the develop- 
ment, regulation, and expression of specific immunity. The interaction between 
T  cytolytic cells (cytolytic T  lymphocytes or CTL) 1 and target cells has proved 
particularly amenable to study. CTL are readily elicited to virus-infected cells or 
to histoincompatible foreign cells. CTL adhere to and lyse target cells bearing 
specific antigen. Adhesion to the target cells requires Mg  +2, while delivery of the 
lethal hit to the target requires Ca  +2. 
Information  on  the  molecular basis of the  CTL-target  interaction  has  been 
obtained with monoclonai antibodies (MAb). MAb to two molecules, Lyt-2,3 and 
LFA-1, block killing by inhibiting formation of the adhesion between the CTL 
and target cell (5-8).  MAb to a  large number of other CTL surface molecules, 
including  some present  in  higher  density,  have no effect on  killing  (9,  10).  It 
appears  that  LFA-1  and  Lyt-2,3  are  distinct  from  the  antigen  receptor,  and 
together with it coiatribute to the avidity of the CTL for the target cell (6,  1 1- 
13). LFA-1 is present on B lymphocytes and myeloid cells as well as T  lymphocytes 
(10),  suggesting that  it plays a  more general  role  in adhesion  than  do antigen 
receptors,  and  might  be a  useful model of other adhesive  interactions  in  cell 
biology. 
Indeed, a  second type of molecule involved in adhesive interactions,  Mac-l, 
has been found to be structurally related to LFA-1 (14, 15). Mac-1 was originally 
defined as a  differentiation  antigen  present on monocyte/macrophage,  granu- 
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locyte, and natural killer (NK) lineages in mice and humans, and absent from B 
and T  lymphocytes (16,  17).  Recently, it  was discovered that  MAb to  Mac-1 
selectively block the complement receptor type three (CRs) on mouse and human 
macrophages and granulocytes (18). Anti-Mac-1 has no effect on macrophage Fc 
receptors or the complement receptor type one (CR 0, suggesting that Mac-1  is 
identical to or functionally associated with the adhesiveness of the CRs.  In an 
interesting resemblance to CTL adhesion, adhesion through the CR3 but not the 
CR1  or Fc receptor is  Mg+2-dependent (19,  20).  The CR3  is a  physiologically 
important receptor on" myeloid cells that is specific for the complement compo- 
nent  C3bi  or  possibly  its  further  degradation  product  C3d,g  (a2D)  (21).  It 
mediates adherence to cells or particles opsonized through either the classical or 
alternative complement pathways with  C3bi  or  C3d,g  (22,  23).  On activated 
macrophages, the CR3 mediates phagocytosis (24, 25). 
LFA-1  and Mac-1  appear very similar in overall structure. They contain a- 
subunits of Mr  180,000  or 170,000,  respectively, and 13-subunits of Mr 95,000. 
Both subunits are glycosylated and have surface exposure (15). In both antigens, 
the subunits are noncovalently associated in  al/31-complexes (14,  15).  Tyrosyl 
tryptic peptide mapping of purified antigens has shown that the 13-subunits are 
very similar or identical, but the a  subunits differ considerably (14). An antigen 
probably identical to LFA-1  was also shown to be related to Mac-1  by peptide 
mapping and MAb cross-reactivity (26).  However, the peptide-mapping results 
should be interpreted with caution. Only the small proportion of peptides that 
contain tyrosine has thus far been mapped, and mapping is sensitive to a single 
amino acid change per peptide. Therefore, important homologies between the 
a-subunits as well as differences between the 13-subunits might have been missed. 
The MAb to LFA-1 that were selected for blockade of CTL-mediated killing 
(9, 27), and the MAb to Mac-1  that block CR3 function (16,  18),  do not cross- 
react (6,  14).  LFA-1  and Mac-1  also bear shared antigenic epitopes, as shown 
both with cross-reactive MAb selected by immunoprecipitation (6, 26), and with 
conventional  antisera  (14).  Whether  the  distinct  and  common  epitopes  are 
present on the a- or/3-subunits has not been known. 
Here,  comparative studies  have  been  carried  out  on  these  cell  interaction 
molecules and their active sites.  The degree of immunological cross-reactivity 
between the subunits of the LFA-1 and Mac-1  molecules is an important measure 
of their  structural  relationship.  Therefore,  conventional  antisera  have  been 
raised to the purified Mac-1  and LFA-1  antigens and to the LFA-1  a-subunit, 
which recognize a broad range of antigenic epitopes, and have been used to test 
subunit crossreactivity. A  panel of noncross-reactive MAb, as well as a  newly 
obtained crossreactive MAb,  have also been  used  to  localize the distinct and 
shared epitopes to specific subunits.  Both types of antibodies show that the a- 
subunits bear the noncross-reactive or "distinct" epitopes, whereas the/3-subunits 
bear  the  common  epitopes  and  are  immunologically identical.  Further,  the 
specificity of MAb  for particular epitopes on  the a- and /3-subunits  has been 
correlated with their effect on T  lymphocyte-mediated killing and macrophage 
complement receptor activity. Functional sites have been localized to the vicinity 
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Materials and Methods 
Antibodies.  Monoclonal  antibodies  (MAb)  recognizing unique  determinants  on  the 
LFA-1  molecule were produced by the  hybridomas M7/14  (9),  M17/4,  M17/5,  and 
M17/7 (27);  those specific for Mac-1  were obtained from the hybridomas M1/70 (16), 
M19/23 and M19/24. The latter M19 hybridomas were obtained by immunization of 
rats with Corynebacterium parvum  macrophages and selection of hybrids for macrophage 
specificity using standard procedures (9, 28). The anti-/3-chain M 18/2 MAb (IgG2aK) was 
obtained by immunization of a rat with mouse CTL glycoproteins purified on lentil-lectin 
columns (29), followed by fusion of spleen cells with the mouse myeloma P3 x 63Ag8.6.5.3 
cell line (28). The M 18/2 hybrid was selected by immunoprecipitation of LFA-1. Hybri- 
doma lines were stabilized by subcloning. Lines grown in RPMI  1640 medium +  10% 
FCS secreted 50-200 #g/ml of MAb and culture supernatants were used either directly 
or after purification of MAb Ig as described (17). 
Polycional rat  antisera  to  homogenous preparations  of purified  LFA-1  and  Mac-1 
antigens (15) were raised by intramuscular injection of 1 ml per rat of an emulsion in 
complete Freund's adjuvant containing 10 #g of purified antigen. The rats were boosted 
subcutaneously after  2  wk  and  1  mo  with  10  #g  of antigen  in  incomplete Freund's 
adjuvant. An antiserum to the a-subunit of LFA-1, separated by preparative SDS-PAGE 
(30),  was  obtained by three different injections of ground and emulsified slices  of gel 
containing the equivalent of 5 #g of LFA-1 a-subunit per boost. 
Purification of Mac-1 and LFA-I.  Mac-1 and LFA-1 were purified from P388D1 or EL- 
4 lysates on MAb-Sepharose-CL 4B columns (15) with the following modifications. The 
final elutions for the anti-LFA-1  M17/4  or M17/7  MAb columns were with  20  mM 
triethylamine, 0.1% TX-100, 1 mM PMSF, pH 11.0, and the M 17/7-Sepharose column 
was additionally eluted with  50 mM triethylamine, 0.5  M  NaCI,  0.1% TX-100,  1 mM 
PMSF pH  11.5. Aliquots of fractions were analyzed by SDS-PAGE and Coomassie Blue 
staining as described (15). 
Iodination, lmmunoprecipitation, and Electrophoresis of Cell Membrane Proteins.  Hypaque- 
Ficoll purified C57BL/6J anti-P815 CTL (2 X 107 cells, viability >90%) and 4-d thiogly- 
collate-induced peritoneal exudate cell macrophages (PEC) (2 X 107 cells, viability >95%) 
were iodinated using chloroglycoluril (IODO-GEN, Pierce Chemical Co., Rockford, IL) 
(31). 
Purified LFA-1 and Mac-1  antigens, and LFA-1 ~- and ~-subunits were iodinated in 
solution using chloroglycoluril (31).  Immunoprecipitation was  performed in two steps. 
The MAb and polyclonal antisera were mixed with labeled cell lysates or purified antigens 
for 2 h  at 4°C, followed by the addition of 40 #l of purified RG7/7.6 mouse anti-rat 
kappa chain coupled to Sepharose (2 mg/ml) (32). After shaking for 1½ h at 4°C, samples 
were washed  and  subjected  to  SDS-PAGE (16)  and  autoradiography with  enhancing 
screens (33). 
Immunoblotting.  Unlabeled thioglycollate-elicited peritoneal exudate cell or P388D~ 
lysates (3.3 ×  107 cells/ml) or EL-4 lysates (5 ×  107 cells/ml) were immunoprecipitated 
with ¼-~ volume of M 1/70-Sepharose (2-3 mg/ml), M 17/4-Sepharose (4 mg/ml), or 
M7/14-Sepharose (2 mg/ml). After shaking for 1½ h at 4°C, the washed immunoprecip- 
....  125-T  itates were subjected to SDS 8% PAGE. Immunopreclpltates containing labeled  I-Mac- 
1 or  ~SI-LFA-1  were included as positive controls for a- and ~-chain transfer and to 
confirm positions of the subunits in immunoblots. The proteins were transferred at room 
temperature to nitrocellulose membranes (Miilipore/Continental Water Systems, Bed- 
ford, MA)  in an Electroblot apparatus (Bio-Rad Laboratories, Richmonds, CA) at 200 
mA  for  15  h  with  water circulation cooling (34).  The  nitrocellulose blots were  then 
saturated with 3% BSA,  1% HoS (horse serum) in phosphate buffer (PBS) plus 0.02% 
(wt/vol) sodium azide at either room temperature overnight or 37°C for 1 h. Blots were 
then cut into strips and incubated with 5 ml of l:l 0 diluted MAb or 1:1,000 dilutions of 
polyclonal antisera in plastic bags. Blots were incubated at 4°C or room temperature for 
2-5 h with gentle shaking, then washed for 30 rain with six changes of PBS,  1% BSA, 
0.3% HoS. Strips were then incubated at room temperature for 2 h with ~sI MAb anti- 
rat kappa chain RG7/7.6 (32) (0.8-1  ×  l0 s cpm/ml) in 100 ml of 3% BSA in PBS, and SANCHEZ-MADRID  ET  AL.  589 
washed for 30 min with four changes of PBS,  1% BSA, 0.3% HoS, and two changes of 
PBS. Dried blots were autoradiographed with intensifying screens (33). 
Dissociation of  Mac-1 a- and O-Subunits by High pH Treatment.  ~SI-labeled Mac-1 (50,000 
cpm/ul) was mixed with 10- to 50-fold (vol/vol) excess of the following solutions: 10 mM 
Tris-HCI, 140 mM NaCI, pH 7.8; 20 mM glycine-NaOH, pH 9.0; 20 mM glycine-NaOH, 
pH 10.0; 20 mM triethylamine, pH 11.0; or 50 mM triethylamine, pH 11.5. The mixtures 
were incubated for 30 min at specified temperatures and then neutralized by addition of 
1/10 volume of 1 M Tris-HCI, pH 6.8. Samples were then assayed by immunoprecipitation 
with the different MAb and antisera. In other experiments, high pH treatment was carried 
out at a series of higher temperatures. 
Absorption of Anti-Mac-1 Serum with Cell Lysates.  P388DI macrophage and EL-4 T  cell 
lines were lysed with Tris-HCl pH  7.8, 0.14 M NaC1,  1 mM PMSF,  1% TX-100 (lysis 
buffer) at cell concentrations of 5 ×  107 cells/ml. Varying volumes of cell lysates  were 
mixed with 10 #1 of 1:200 diluted anti-Mac-1 serum, and samples were adjusted to 100 #1 
with lysis buffer and incubated overnight at 4°C. After centrifugation at 2,000 rpm × 20 
min, the absorbed supernatants were tested for immunoprecipitation of ~25I-labeled Mac- 
1 antigen which had been previously dissociated by treatment at pH 11.5 at 30°C for 30 
min. 
CTL Generation and Assay.  Generation of effector cells and inhibition of mouse CTL- 
mediated cytolysis using C57BL/6J anti-P815 (ailogeneic) and C57BL/6J anti-rat BNL4~ 
(xenogeneic) effector cells were performed and percentages of specific 5~Cr release and 
inhibition of killing activity were calculated as described (5, 27). 
CR3 Rosette Analysis.  The rosetting assays were performed essentially as described by 
Beller et  al.  (18)  but  adapted  to  50  #!  final  volume in  96-well  plates  (Costar,  Data 
Packaging,  Cambridge,  MA).  Briefly, 25  ×  l0 s  4-d  thioglycollate-induced peritoneal 
exudate cells from C57BL/6J mice were plated in 40 ~1 of Hank's balanced salt solution, 
I 0 mM HEPES per well.  MAb were added in 5 #1 to triplicate wells either undiluted or 
diluted with  10% BSA in Hank's balanced salt solution/HEPES. After 10 min at room 
temperature, 5 #i of an opsonized sheep erythrocyte (SRBC) suspension was added. The 
cultures  were  incubated  for  30  rain  and  then  washed  gently  4-5  times  to  remove 
nonadhered SRBC. Monolayers were fixed in 1% glutaraldehyde and the percentage of 
macrophages rosetting 5 or more SRBC was determined on an inverted microscope. 
Opsonization of SRBC was carried out as previously described (18), except that the 
anti-Forssman antigen M1/87.27 IgM MAb (35) was used at the maximal nonagglutinat- 
ing concentration of 1:32 to sensitize a 2% suspension of washed SRBC. C5-deficient A/ 
J mouse serum was used as the complement source. 
Results 
Distinct  and Common  Epitopes  on the LFA-I and Mac-1 Molecules.  A  panel of 9 
MAb and 3 conventional antisera were tested for cross-reactivity by immunopre- 
cipitation of LFA-1 and Mac-1 from lysates of 125I-labeled cytolytic T  lymphocytes 
and  macrophages,  respectively (Fig.  1).  Four independent  MAb  to  LFA-1  ob- 
tained  by selection  for blockade  of CTL-mediated  killing  precipitated  LFA-1 
from CTL (Fig.  1 A, lanes 2-5), but nothing from macrophages (Fig.  1 B, lanes 
2-5).  Four  independent  MAb  to  Mac-1  selected  for  macrophage-specificity 
precipitated Mac-1  from macrophages (Fig.  1 B, lanes  7-10), but nothing from 
CTL (Fig.  1 A, lanes 7-10). These two groups of MAb thus recognize noncross- 
reactive or "distinct" epitopes on the LFA-1  and Mac-1  molecules. In contrast, 
the  M18/2  MAb  precipitated  LFA-1  and  Mac-1  equally well (Fig.  1A  and B, 
lane 6). This MAb thus defines a  crossreactive or "common" epitope. Conven- 
tional antisera,  raised to Mac-I  or LFA-1  purified by MAb affinity chromatog- 
raphy, were also cross-reactive (Fig.  1A and B, lanes 12 and 13). 
Interestingly,  the  antibodies  which  recognize common epitopes precipitated 590  MAPPING  OF  ANTIGENIC  AND  FUNCTIONAL  EPITOPES 
FIGURE  1.  LFA-1  and Mac-1 bear distinct and common antigenic determinants. Spleen cells 
from B6 mice primed with P815 and restimulated in vitro (CTL anti-P815) (A and D), 4-day 
thioglycollate-elicited  peritoneal exudate cells (PEC) (B and C), and 4-day Con A-stimulated 
spleen cells (T cell blasts) (E) were labeled with 125I. Cell lysates  were immunoprecipitated with 
100 #1 of supernatants of NSI plus 50 t~g/ml normal rat IgG as control (lane I); the anti-LFA- 
1 M7/14, M17/4, M17/5 and M17/7 MAb (lanes 2-5, respectively);  the M18/2 MAb (lane 
6); the anti-Mac-1 M1/70, M19/23, M19/24, and M19/1 MAb (lanes 7-10, respectively);  or 
with 1 ~1 normal rat serum (lane 11); or antisera to purified Mac-1 (lane 12), LFA-1 (lane 13), 
or LFA-I a-chain (lane 14). Immune complexes were precipitaed with anti-rat kappa chain 
MAb coupled to Sepharose. Reduced samples were subjected to SDS 10% PAGE and autora- 
diography. 
an additional a-like band of 155,000 Mr from CTL and macrophage preparations 
(Fig. 1 A and B, lanes 6, 12, 13). This band is the same Mr in both cell preparations, 
while the Mr's of the LFA-1 and Mac-1 a-chains differ. Since it is precipitated by 
crossreactive but not by noncross-reactive MAb  (Fig.  1),  the  155,000 Mr band 
does not appear to be a  degradation product. Trypsin and papain degradation 
products of Mac-1  are precipitated equally efficiently by crossreactive and non- 
crossreactive MAb (data not shown). Therefore, this band may represent a third 
member of the LFA-1 and Mac-1  family. 
Another conventional antiserum was raised to LFA-1 a-chain which had been 
separated from LFA-1  /3-chain by preparative SDS-PAGE.  Anti-LFA-1  a  chain 
serum precipitated LFA-1 a-chain, with little or no associated 0-chain from CTL, 
and no Mac-1 from macrophages (Fig.  1 C and D, lane 14). The amount of LFA- 
1 a-chain precipitated varied from high in some preparations (Fig.  1 E, lane 14), 
to none in others (not shown), probably due to differences in the amount of a- 
chain which has become dissociated from the/3-subunit. The anti-LFA-1 a-chain 
serum appears predominantly specific for free LFA-1  a-chain as opposed to the 
native LFA-1 al/31-complex. 
Localization of Epitopes with lmmunoblotting.  To localize epitopes to the a- or/3- 
subunits,  unlabeled  subunits  were separated  by SDS-PAGE and transferred  to 
nitrocellulose.  Blots  were  probed  with  the  rat  antibodies  to  LFA-1  or  Mac-l, SANCHEZ-MADRID  ET  AL.  591 
then with a second l~5I-labeled anti-rat kappa chain MAb (32). The 3-subunits of 
both Mac-1  and LFA-1  reacted with anti-Mac-1  serum (Fig. 2A, lanes 2 and 5), 
with anti-LFA-1 serum (Fig. 2 A, lanes 3 and 6), and with the cross-reactive M 18/ 
2  MAb (Fig.  2B,  lanes 2  and 3).  This shows that common epitopes recognized 
by conventional antibodies and by a monoclonal antibody are present on the 3- 
subunits. Reaction of antibodies with the 3-subunits was found after SDS-PAGE 
under nonreducing conditions (Fig.  2A-C), but not under reducing conditions 
(Fig. 2D). This showed that the 3-subunits contain disulfide bonds, and that they 
are important for proper renaturation. 
None  of 8  MAb  that  defined  specific epitopes  reacted  in  immunoblotting, 
despite use of nonreducing conditions (data not shown). The anti-Mac-1  serum 
reacted with the Mac-1  a-chain (Fig. 2A, lane 2; Fig. 2C, lanes 1 and 3; Fig. 2D, 
lanes 5 and 7), but not with the LFA-1  a  chain (Fig. 2A, lane 5; Fig. 2C, lane 2; 
Fig.  2D,  lane  6).  Reactivity of anti-Mac-1  serum  with  the  Mac-1  a-chain  was 
retained even after reduction (compare Fig. 2 C and Fig. 2D). 
Localization of Specific LFA-1 Epitopes to the a-Subunit.  The subunit reactivity 
FIGURE 2.  Localization ofcross-reactive determinants on the 0-subunits by immunoblotting. 
Unlabeled Mac-1  and LFA-1 antigens were purified from thioglycollate-induced MO and EL- 
4  lysates, respectively, using the anti-Mac-1  MI/70  MAb and the anti-LFA-1  M17/4  MAb 
coupled  to  Sepharose.  The  immunoprecipitates  were  subjected  to  SDS-8%  PAGE  under 
nonreducing (A-C) or reducing (D) conditions and transferred  to nitrocellulose blots.  In B, 
lane 1,125I-LFA-1  was run side by side with unlabeled antigens and transferred to nitrocellulose 
as a positive control for a- and/3-transfer and as a Mr marker. Strips of the nitrocellulose blots 
containing LFA-I or Mac-1  antigen as indicated in the figure were incubated with  1/1,000 
diluted normal rat serum (-4, lanes 1 and 4), anti-Mac-1 serum (A, lanes 2 and 5; C, lanes 1-3; 
D, lanes 5-7), anti-LFA-1 serum (.4, lanes 3 and 6), or 1/10 diluted M18/2  MAb (B, lanes 2 
and 3; C, lane 4; D, lane 4).  In A and B, antigen from 42/~1 of lysate was used per strip. In C 
and D, the LFA-I antigen was from 750 #1 lysate/lane, while the Mac-I antigen was from a 
lysate volume of 250 t~l (lane 1),  120 #1 (lane 3), 370 #1 (lane 5), or 190 #1 (lane 7). 1~5I anti-rat 
kappa chain MAb was used as second antibody. Blots were autoradiographed. 592  MAPPING  OF  ANTIGENIC  AND  FUNCTIONAL  EPITOPES 
of MAb which bind to noncross-reactive epitopes on LFA-1 was studied with two 
different anti-LFA-1 MAb coupled to Sepharose. During large scale purification, 
LFA-1  from  EL-4  cells  was  absorbed  to  M17/4  or  M17/7  MAb-Sepharose 
affinity columns. Upon elution of the M17/4  column with pH  11  buffer, small 
amounts of (a chain and large amounts of/3 appeared in early fractions (Fig. 3A, 
lanes 1-2),  while a  was greatly enriched in later fractions (Fig.  3A, lanes 4-6). 
Similarly, when the M 17/7 column was used, pH  11 buffer eluted largely/3 with 
only small amounts of a  (Fig. 3B, lanes 1-8), while pH  11.5 eluted a and/3 (Fig. 
3B, lane 11),  followed in later fractions by very high ratios of a  to/3 or a  only 
(Fig.  3B,  lanes  12-14).  Thus the a-chain can remain bound to the M17/4  or 
M17/7  MAb  after /3 is dissociated from  a,  showing that  a  bears the  LFA-1- 
specific antigenic determinants. 
It appears  that  this  antigenic epitope  is  lost  after a  elutes  from the  MAb- 
Sepharose column, probably due to a conformational change when the subunits 
become dissociated.  This  was  shown  using  fractions eluted  from  the  affinity 
columns and labeled with 12~I, and which were enriched for LFA-1 a-chains (Fig. 
4A, lane 2) or/3-chains (Fig. 4A, lane 3). The l~5I-labeled LFA-1  a  could not be 
rebound by the same LFA-1  MAb with which it was purified (Fig. 4B, lane 9), 
but  was  strongly bound  by anti-LFA-1  a-serum  (Fig.  4B,  lane  7).  A  positive 
control showed the anti-LFA-1  MAb  precipitated the  al/3~-complex from  the 
preparation enriched for/3-chains (Fig. 4 C, lane 9). In contrast, the M 18/2 anti- 
/3 MAb precipitated large amounts of free/3 chain in addition to the al/3x-complex 
(Fig. 4C, lane 10). 
Epitopes on the Dissociated Mac-1 a- and ~-Subunits.  The Mac- 1 a- and/3-subunits 
remain associated after elution from anti-Mac-1  MAb-Sepharose at pH  11.  To 
determine conditions for dissociation, purified l~SI-labeled  Mac-1 was treated at 
various  pH's  for  30  min.  at  0°C,  neutralized,  and  samples  were  tested  by 
FIGURE 3.  Differential elution of LFA-1  a- and ~/-subunits  from MAb immunoadsorbents. 
Lysates were prepared  from EL-4 cells and applied to Sepharose columns coupled with the 
anti-LFA-1  M17/4  or  M17/7  MAb.  The columns  were washed  and  eluted  with high  pH 
buffers. Analyses of aliquots of fractions eluted with pH 11.0 buffer from the M 17/4 (A, lanes 
1-7) and M17/7 (B, lanes 1-10) columns and subsequent elution of the M17/7 column with 
pH  11.5 buffer (B, lanes 11-14) were performed by SDS-PAGE and Coomasie Blue staining. SANCHEZ-MADRID  ET  AL.  593 
FIGURE 4.  Immunoprecipitation of l~5I-labeled LFA-1 preparations enriched in the a- or B" 
subunit.  Preparations of LFA-1 containing similar amounts of a  and B, enriched in a,  or 
enriched in B (corresponding to fractions analyzed in Fig. 3A, lanes 1 and 6; and Fig. 3B, lane 
2, respectively) were labeled with ~5I and analyzed by SDS-10% PAGE and autoradiography 
either directly (A, lanes 1, 2, and 3, respectively) or after immunoprecipitation. Preparations 
enriched in a (B) or B (C) were mixed with nonimmune rat serum as control, lane 4; anti-Mac- 
1 serum,  lane 5; anti-LFA-1 serum, lane 6; anti-LFA-1 a  serum, lane 7; and the following 
MAb: NSI culture supernatant as control, lane 8; anti-LFA-I M17/7 MAb, lane 9; and anti- 
LFA-1 B-chain M18/2  MAb, lane 10.  Anti-rat kappa chain MAb coupled to Sepharose was 
used as second antibody. 
FIGURE 5.  pH-Dependent dissociation of the Mac-I or- and Bosubunits. 1~sI-labeled, purified 
Mac-1 (1 #1) was diluted with 50 tA of solutions of pH 10.0 (A), pH 11.0 (B), and pH 11.5 (C) 
for 30 min. at 0°C. The samples were neutralized and tested by immunoprecipitation with 
nonimmune rat serum as control, lane I; anti-Mac-I serum, lane 2; anti-LFA-1 serum, lane 3; 
anti-LFA-1 a serum, lane 4; and the following MAb: NSI culture supernatant as control, lane 
5; anti-Mac-1  M19/23  MAb, lane 6; anti-//chain M18/2  MAb, lane 7. Immune complexes 
were isolated with anti-rat kappa chain MAb-Sepharose and subjected to SDS 10%-PAGE and 
autoradiography. 
immunoprecipitation  with  the  antisera  and  MAb  to  Mac-1.  The  results  after 
treatment  at pH  7.8  and  9  (not shown),  pH  10  (Fig.  5A), and  pH  11  (Fig.  5B) 
were  identical:  the  Mac-1  a-  and/3-subunits  remained  associated  as  shown  by 
precipitation of both subunits by the M 18/2  anti-C/MAb (Fig. 5A, B, lane 7) and 
the M19/23  Mac-l-specific MAb (Fig. 5A and B, lane 6). Treatment  at pH  11.5 
caused dissociation of the a- and/3-subunits,  as shown  by precipitation of the 13- 594  MAPPING  OF  ANTIGENIC AND  FUNCTIONAL EPITOPES 
subunit but no a-subunit by anti-LFA-1  serum and the M 18/2 anti-B MAb (Fig. 
5 C, lanes 3  and 7). Concomitantly with dissociation, the determinant defined by 
the Mac-1-specific M 19/23  MAb was lost (Fig. 5 C, lane 6). The Mac-1 antiserum 
precipitated both a  and B, showing that it contained two populations of antibod- 
ies,  one  reactive  with  the  a-subunit  and  the  other  reactive  with  the  B-subunit 
(Fig. 5 C, lane 2). 
Non-cross-reactivity of Mac-1  and LFA-1 a-Chains.  The conventional antisera to 
Mac-1  and  to  LFA-1  a-chain  were  used  to  test for the presence of any shared 
epitopes  on  the  Mac-1  and  LFA-1  a-chains.  ~25I-Mac-1  antigen  that  had  been 
completely dissociated  by treatment  with  pH  11.5  at  25°C  as verified with  the 
anti-B  MAb  (Fig.  6E,  lane  9)  and  a-chain  enriched,  dissociated  ~25I-LFA-1 
preparations were  used.  Serial  dilutions  of antisera  showed  the  LFA-1  a-chain 
was precipitated by as little as  1/25  ~1 of anti-LFA-1  a-serum (Fig.  6D, lane  4), 
while  up  to  4  #1  gave no  precipitation  of the  Mac-1  a-chain  (Fig.  6C,  lane  1). 
This showed specificity for the  LFA-1  a-chain was >100-fold.  Conversely, 4  #1 
of anti-Mac-1  serum did not precipitate LFA-1  a  (Fig.  6B, lane  1), but  1/125  ~1 
precipitated the Mac-1  a-chain (Fig. 6A, lane 5), showing specificity for Mac-1  a 
was  >500-fold.  In  contrast,  0-chain  specific  antibodies  in  anti-Mac-1  serum 
precipitated Mac-1 B-chain and small amounts of B-chain present in the enriched 
LFA-1  a-chain  preparation  equivalently at a  concentration  range of 4/~1  to  1/ 
125  #1 (Fig.  6A and B,  lanes  1-5).  The anti-LFA-1  a-serum did not precipitate 
any LFA-1  or Mac-1  B-chain, confirming it was completely specific for LFA-1  a. 
The above experiments showed that the dissociated a-subunits were not cross- 
reactive, while  the dissociated ~-subunits were cross-reactive. It was next tested 
FIGURE 6.  Lack of cross-reaction between the a-subunits with conventional sera to Mac-1 
and to LFA-1 a-chain. Serial dilutions of anti-Mac-1 serum (A and B) and anti-LFA-1 a chain 
serum (C and D) were tested for immunoprecipitation of liSI-labeled purified Mac-1 a- and/~- 
subunits that had been dissociated at pH 11:5 at 25°C for 30 min (A and C) or of t~SI-labeled, 
pH-dissociated LFA-I preparation that was enriched  in a chains (B and D). The amounts of 
sera were 4 #1 (lane 1), 1 #! (lane 2), 1/5 #1 (lane 3),  1/25 #1 (lane 4), 1/125 #1 (lane 5),  1/ 
625 #1 (lane 6), 1/3,125 #1 (lane 7), or 1/15,625 #l (lane 8) diluted in a final volume of 20 #1. 
Immunoprecipitation  of dissociated ~5I-Mac-1 (E) with the M  18/2 anti-B-chain MAb (lane 9) 
and the M  19/23 anti-Mac-1 MAb (lane 10) showed Mac-1 dissociation was complete.  Nonim- 
mune rat serum (4 #l) was used as a control for specific immunoprecipitation (lane 1  I). Immune 
complexes were isolated with anti-rat kappa chain MAb-Sepharose and subjected to SDS 8%- 
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whether this also held for the a- and #-subunits in the native ad31-complex. Anti- 
Mac-1  serum was used, which had been raised to the ale/i-complex and reacted 
with the native complex as well as the dissociated a- and #-subunits.  Anti-Mac-1 
serum was absorbed with cells of the Mac-1 + P388D1 macrophagelike line or the 
LFA-1 + EL-4 T  lymphoma line (15), which had been solubilized with Triton X- 
100  to expose intracellular as  well as extracellular portions of the  Mac-1  and 
LFA-1 molecules. The absorbed serum was then tested for immunoprecipitation 
of the dissociated Mac-1  a- and #-subunits that were quantitated by scanning of 
autoradiograms. The anti-# activity in the serum was removed to the same extent 
by P388DI  or EL-4 lysates (Fig.  7B), suggesting  that all 13-determinants recog- 
nized by the anti-Mac-1  serum  are  common to  Mac-1  and  LFA-1.  Equivalent 
absorption by P388D~  and  EL-4 was  in agreement with previous findings that 
they have similar densities of Mac-1 and LFA-1, respectively (15). P388D1 lysates 
but not  EL-4 lysates absorbed  the reactivity of the anti-Mac-1  serum  with  the 
Mac-1  a-subunit  (Fig.  7).  Mac-1  and  LFA-1  remain in the native oq#rcomplex 
after solubilization with Triton X-100 (15). No dissociation of the Mac-1 subunits 
in Triton  X-100 was  seen at neutral pH  (cf.  Fig.  5).  Thus,  it appears that  the 
anti-Mac-1  antibodies that immunoprecipitate the dissociated a- and #-subunits 
were absorbed by the native al/31-complex. These results confirm the absence of 
common determinants on the a-chains of the native Mac-1 and LFA-1 molecules, 
and show the #-subunits are immunologically identical. 
Differential  Functional  Effects of MAb  to a- and  13-Epitopes.  The above studies 
showed that antibodies specific for Mac-1  or LFA-1  recognized epitopes on the 
a-subunits  while cross-reactive antibodies recognized #-subunit epitopes. It was 
of great interest to explore whether antibodies binding to epitopes on the a- and 
#-subunits differed in their functional effects. Preliminary experiments utilizing 
100, 
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FIGURE 7.  Absorption of anti- a- and anti- /S-antibodies in anti-Mac-1 serum by P388D1 
(Mac-1  +) or EL-4 (LFA-1  +) cell lines. Anti-Mac-I serum (10 #1 of a  1/200 dilution) was 
adsorbed with 100 pl of lysis buffer (no absorption control) or with the indicated number of 
P388D~ (0) or EL-4 (A) cells in 100 #1 of lysis buffer as described in materials and methods. 
The absorbed antisera were used to immunoprecipitate 125I-purified  Mac-1 a- and B-subunits 
which had been dissociated  by treatment with a 50-fold volume excess  ofpH 11.5 triethylamine 
for 30 min at 30°C and neutralized. Immunoprecipitates were subjected to SDS-10% PAGE 
and autoradiography with hypersensitized film and enhancing screens (33). The amount of 
precipitated Mac-1 a-chain (A) or # chain (B) was quantitated by scanning the autoradiograms. 
Lack of precipitation by the M19/23  MAb and precipitation of the B-subunit only by the 
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immunofluorescence  and binding of ~25I-labeled MAb to intact cells showed that 
both anti-a and anti-/3 MAb bind to cell surface epitopes, that the a- and 0-chain 
epitopes are topographically distinct as shown by lack of competitive inhibition, 
and that concentrations of MAb used in functional experiments gave saturation 
of binding (data not shown). Preclearing experiments confirmed that anti-/3 and 
the appropriate anti-a MAb bound to the same population of Mac-1  or LFA-1 
molecules (not shown). Inhibitory effects were tested in two different cytolytic T 
lymphocyte assays employing B6 mouse killer T lymphocytes specific for antigens 
on allogeneic P815 mouse target cells or xenogeneic BN lymphoma rat target 
cells, respectively. The anti-LFA-1  a-chain MAb gave >85% of inhibition of T 
cell-mediated cytolysis in both the allogeneic and the xenogeneic killing systems, 
but the anti-0-chain M18/2  MAb had no effect (Table I).  MAb were similarly 
tested  for  inhibition  of adherence  of erythrocytes  sensitized  with  IgM  and 
complement to the complement receptor type 3  (CRy) on macrophages. The 
M1/70  and  M19/23  MAb  specific  for  Mac-1  gave  strong inhibition of the 
percentage of macrophages forming rosettes with C3bi-sensitized erythrocytes 
(Table I). The M 1/70 and M 19/23 MAb recognize the same or spatially related 
epitopes, since they mutually inhibit each other's binding (not shown). The M 19/ 
24 MAb recognizes a spatially distinct epitope on the a-chain, since it does not 
cross-compete with M 1/70 or M 19/23 (not shown). Interestingly, M19/24 did 
not inhibit the CRs (Table I). The anti-/3-chain  M18/2 MAb did not block CRs 
activity, but in contrast, enhanced the percentage of rosetting macrophages by 
TABLE  1 
Effect of MAb on CTL-Mediated Killing and Complement Receptor Activity 
Specificity  MAb 
A.  Killing Activity  B.  E-IgM-C Ro- 
setting 
B6 Anti-BNLO  B6 anti-P815 
Specific  Inhibi-  Specific  Inhibi-  Roset-  Inhibition  release  tion  release  tion  ting 
%  %  %  %  %  % 
Control  M1/69HK  52.5  --  51.0  --  75  -- 
Anti- LFA-1  a  M17/4  0.6  99  3.3  94  71  5 
Anti- LFA-I  a  M17/5  0.9  98  2.3  96  74  1 
Anti- LFA-1  a  M17/7  0.4  99  8.1  85  71  5 
Anti-/3  M18/2  49.0  6  62.6  0  94  -25 
Anti-Mac-I a  M1/70  51.2  0  51.8  3  8  89 
Anti-Mac-1 a  M19/23  55.0  0  61.8  0  3  96 
Anti-Mac-1 a  M19/24  59.0  0  58.9  0  71  5 
(A)  Secondary (1-1) xenogeneic C57BL/6J (B6) mouse anti-rat BNLO CTL (E:T=10:1) or primary 
(0-1) allogeneic anti-P815 CTL  (E:T=2:I) were pretreated with an equal volume of MAb in 
5t  hybridoma culture supernatants for 15 rain at room temperature, then  Cr-labeled target cells 
were added and the assay was completed. The spontaneous release of 5~Cr in wells containing 
the appropriate culture supernatant but with effector cells omitted was 3% and 14%, respectively. 
Percent of inhibition of specific 5~Cr release is expressed relative to CTL treated with culture 
supernatant of the inactive M 1/69 HK hybridoma which has lost its specific L chain. 
(B)  Macrophages adherent to microtiter wells were pretreated for 10 min. at room temperature with 
10% hybridoma culture supernatant. Then sheep erythrocytes coated with IgM (E-IgM) or with 
IgM followed by C5-deficient complement (E-IgM-C) were added and the assay was completed. 
Wells with E-IgM had 0%  rosettes.  Percent of inhibition of rosetting is expressed relative to 
cultures with M I/69 HK culture supernatants. SANCHEZ-MADRID  ET  AL.  597 
25% (Table I). This enhancing effect has been repeatedly demonstrated and is 
considerably more dramatic (up to  100%)  when erythrocytes are suboptimally 
sensitized with complement and control rosetting is <50%. ~ As expected, MAb 
specific for Mac-1  or LFA-1  had no effect on CTL-mediated killing or CRs- 
mediated adherence, respectively (Table I). 
Discussion 
Cell-cell adhesions are of crucial importance in the development and differ- 
entiation of higher organisms. Here, two molecules involved in adhesive inter- 
actions  have  been  compared  and  their  functional  sites  have  been  localized. 
Previously, the structural basis of the common and distinct epitopes (14, 26) on 
the Mac-1 and LFA-1  molecules had been unknown. The present studies show 
that the immunological cross-reactivity between the Mac-I and LFA-1 antigens 
is  due  to  their  /3-subunits.  To  explore  the  widest  possible  range  of antigen 
epitopes,  conventional antisera  were raised to  the purified Mac-1  and  LFA-1 
antigens. Crossreactions occurred only with the/3-subunit of the heterologous 
antigen, as shown by immunoblotting after SDS-PAGE and by immunoprecipi- 
tation after dissociation of subunits by high pH treatment. A cross-reactive MAb 
was also shown to bind to the LFA-1 and Mac-1 /3-subunits.  Moreover, conven- 
tional  sera  had  equal  titer  for  LFA-1  and  Mac-1  /3-subunits,  and  cell  lysates 
containing  LFA-1  were  as  effective as  those  containing  Mac-1  in  absorbing 
antibodies to the Mac-1  /3-subunit present in  anti-Mac-1  serum. These results 
show the LFA-1  and Mac-1  /3-subunits are immunologically identical. Previous 
studies had shown the/3-subunits have essentially identical tyrosyl tryptic peptide 
maps,  but  differences among nontyrosyl peptides,  which are  normally more 
numerous, could not be ruled out (14, 26). Taken together, these findings now 
show there is a high degree of identity between the Mac-1 and LFA-1/3-subunits, 
and that they could be encoded by a single gene. 
The  Mac-1  and  LFA-1  a-subunits  have  been  shown  to  bear  the  distinct 
epitopes.  Despite the use of polyclonal antisera at concentrations  100- to 500- 
fold higher than required for reaction with the homologous o~-subunits, no cross- 
reaction between the a-subunits was found. Anti-a-chain activity of anti-Mac-1 
serum was absorbed by Mac-1 + macrophage lysates but not by LFA-1 + lympho- 
cyte lysates. Furthermore, distinct determinants recognized by MAb to LFA-1 
were located on the ot-subunit as demonstrated by differential elution from MAb- 
Sepharose columns with dissociative high pH treatment. It can be deduced from 
the non-cross-reactivity of the a-subunits and the complete cross-reactivity of the 
/3-subunits  as  shown  by conventional antisera,  that  the  MAb-defined, distinct 
epitopes on  Mac-1  are also present on the a-subunit.  The non-cross-reactivity 
shows there are extensive differences between the a-subunits, in agreement with 
tyrosyl tryptic map data (14, 26). It should be emphasized that many homologous 
proteins show no cross-reactivity or peptide map identities. A single amino acid 
substitution per peptide or determinant would generate differences. As a general 
rule for globular proteins, 60% sequence homology is required for cross-reaction 
to occur (36, 37). In analogy to other protein families with shared subunits, e.g. 
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the hemoglobins, immunoglobulins, and class  I histocompatibility antigens, the 
a-chains are predicted to be homologous at the level of amino acid sequence. 
MAb-defined epitopes  on  the  LFA-1  and  Mac-1  a-subunits  were lost  after 
dissociation from /3 with high  pH.  Conversely, the antisera prepared to  SDS- 
denatured, purified LFA-1  a  reacted with the free LFA-1  a-chain but not with 
the  ad31-complex.  A  similar  dependence  of  HLA  a-chain  conformation  on 
association  with  the  /3-2m  subunit  has  been  reported  (38).  The  most  likely 
interpretation is that conformational changes occur in a  after dissociation from 
/3, but it is also possible that all these antibodies recognize epitopes in the region 
of a/3-contact. A  proportion of the antibodies to the Mac-1  al/31-complex were 
reactive with  the  free  Mac-1  a-chain.  These  may be  high  affinity antibodies 
which can "capture" the dissociated a-chain in a  conformation resembling the 
native one. Intact disulfide bonds were required for proper renaturation of/3- 
chain epitopes after SDS-PAGE, but no dependence of/3-epitope conformation 
on association with the a-chain was detected. 
The finding that epitopes could be localized to the a- and/3-chains raised the 
question  of whether MAb binding to  different epitopes would differ in  their 
effects  on  function.  Two  anti-Mac-1  a  MAb  (M1/70  and  M19/23)  which 
compete for the same topographic determinant on the a  subunit strongly inhib- 
ited CRs activity. The M 19/24 MAb which recognizes a second, topographically 
distinct  epitope  on  the  Mac-1  a-chain,  did  not  show  any  inhibitory  effect. 
Furthermore, binding of the M18/2  MAb to  Mac-1  13-subunit did not inhibit 
complement receptor activity. A functionally important site has thus been local- 
ized to the vicinity of the M1/70-M19/23  epitope on the a-subunit. This may 
be a receptor site for binding of the C3bi ligand. In a similar fashion, three anti- 
LFA-1  MAb that recognize identical or closely related epitopes (27) on the a- 
subunit gave strong inhibition of CTL-mediated killing, while the anti-/3  MAb 
gave no inhibition. 
Functional  sites  on  the  LFA-1  molecules and  Mac-1  thus  both  map  to  the 
vicinity  of specific  epitopes  on  the  a-subunits.  The  findings  emphasize  the 
importance of these  sites,  but  do  not  rule  out  the  possibility  that  additional 
functional sites might be found with appropriate MAb. The simplest interpreta- 
tion is that  the a-subunit sites defined here function in adhesion, and that  a- 
chain divergence reflects specialization  for binding  of distinct  ligands.  Mac-1 
may bind C3bi,  while the ligand for LFA-1  remains unidentified. A  ligand for 
LFA-1 might normally be present on target cells, or deposited on them by CTL. 
It is possible that further members of the LFA-1 and Mac-1 family exist which 
are specialized for binding of other ligands.  The  a-like chain of 155,000  Mr 
precipitated by anti-/3-antibodies might represent a distinct member of this family. 
It is of interest that a  150,000 Mr glycoprotein has been shown by MAb blocking 
studies and  by  its  deficiency in  Bernard Soulier syndrome to  be  involved in 
platelet adhesion to the subendothelial surface (39). 
The Mac-1  and LFA-1 antigens are selectively expressed on some ieukocytes, 
such as thioglycollate-elicited macrophages and lymphocytes, respectively, and 
are co-expressed on others, such as granulocytes and NK cells. The MAb used 
to define and to  distinguish between these antigens have now been shown to 
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epitopes.  The  LFA-1  and  Mac-1  gene family appears ideally suited for studies 
on the regulation of gene expression during leukocyte differentiation. There are 
at least two a-chain genes and one B-chain gene. Biosynthesis studies have shown 
the  mature  antigens  are  derived from  the assembly of the  separate  a- and  /3- 
precursors, implying the a- and B-genes are separate (40). Cloning of the genes 
would allow studies on how a-genes are selectively expressed and how a- and B- 
expression is coordinated. A particularly interesting system is the M 1 myelomon- 
ocytic cell line, which is Mac-l- but becomes strongly Mac-1 + after maturation 
to a macrophage phenotype is induced with corticosteroids or lymphokines (41). 
Cloning should be facilitated by the antisera described here that react with the 
separated  a-  and  B-subunits.  They would be expected  to bind  to  the  nascent 
chains on polyribosomes, allowing isolation of specific mRNA's (42), and to allow 
immunoprecipitation  of in vitro translation products. 
The human homologues of LFA-1 and Mac-1 have been found. Human LFA- 
1 is  important  in  anti-HLA-DR and  anti-HLA-A,B  CTL-mediated  killing  and 
appears identical  to murine  LFA-1 in subunit composition and cell distribution 
(43). The rat anti-mouse Mac-1 M1/70 MAb cross-reacts with human Mac-1 and 
locks the human  CR3 (18).  The  OKM1  MAb also blocks the CR3,  3 suggesting 
human  Mac-1 and OKM1 are identical as was expected from their cell distribu- 
tions (17,  44).  Recently, a  MAb has been found that  cross-reacts with  human 
LFA-1  and  Mac-1  (OKM1)  antigens,  and  the  epitope  it  recognizes  has  been 
localized on the B-subunit of both antigens, s The functional significance of this 
protein  family  and  its  subunit  organization  is  emphasized  by conservation  in 
evolution. 
Summary 
Mouse Mac-l, a  complement receptor-associated surface structure on macro- 
phages, and LFA-1, a function-associated structure on lymphocytes, comprise a 
novel family of leukocyte differentiation  antigens participating  in adhesive cell 
interactions.  Mac-1  and LFA-1  contain a-subunits of 170,000 and  180,000 Mr, 
respectively, and B-subunits of 95,000 Mr noncovalently associated in alB1 com- 
plexes. The structural  relation between the a- and between the B-subunits, and 
the location of functionally important  sites on the molecules, have been probed 
with antibodies. Both non-cross-reactive and cross-reactive monoclonal antibodies 
(MAb) and antisera prepared to the purified molecules or the LFA-1 a-subunits 
were used. Reactivity with individual subunits was studied by immunoprecipita- 
tion  after  dissociation  induced  by high  pH  treatment,  or  by immunoblotting 
after SDS-PAGE. Cross-reactive epitopes on Mac-1 and LFA-1 were found to be 
present  on  the  B-subunits,  which  were  immunologically  identical.  Non-cross- 
reactive epitopes that are distinctive for Mac-1  or LFA-1  were localized to the 
a-subunits.  MAb to  LFA-1  a-subunit epitopes inhibited  CTL-mediated killing. 
Two MAb to Mac-1 a-subunit epitopes but not a third MAb to a spatially distinct 
a-epitope inhibited complement receptor function.  Neither function was inhib- 
ited by a MAb binding to a common B-subunit epitope. Therefore, sites of Mac- 
1 and  LFA-1  involved in their  respective adhesion-related  functions, as well as 
3 F. Sanchez-Madrid, J. Nagy, E. Robbins, P. Simon, and T. Springer, manuscript submitted. 600  MAPPING OF ANTIGENIC  AND  FUNCTIONAL  EPITOPES 
distinctive structural features, have been localized to the ~-subunits. 
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